EQT Agrees to Buy Qiagen for EUR46.50 per Share

QIAGEN agreed to a recommended all-cash takeover by EQT at €46.50 per share, valuing the company at about €10.8B EV. The offer needs at least 50%+1 share acceptance, EGM approvals, and regulatory clearances; closing is expected in mid-2027.Material DetailsContext by AI AnalystThis is a late-stage c…